International perspectives on AI-driven pharmaceutical IP challenges
Frontiers in Digital Health · 22.06.2026 · 8
DOI: 10.3389/fdgth.2026.1774406 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Digital Health, online erschienen am 22.06.2026. Verfasst von Grace Y Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: West Windsor High School-North, West Windsor, NJ, United States. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Artificial Intelligence (AI) is transforming the pharmaceutical sector by optimizing care delivery and accelerating drug design. While AI introduces significant benefits, it presents complex challenges regarding intellectual property (IP) frameworks. This review examines AI-driven innovations in personalized medicine and drug design, with a specific focus on inventorship issues that directly affect pharmaceutical patent protection. We analyze recent United States (US) legal developments concerning AI inventorship, including the US Supreme Court's March 2026 denial of certiorari in Thaler v. Perlmutter, which definitively resolved the question of AI inventorship under US law, provide comparative analyses of approaches in Germany and China, and identify specific lessons, rather than wholesale reforms, that may help stakeholders navigate the evolving intersection of AI and pharmaceutical IP.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- West Windsor High School-North, West Windsor, NJ, United States.
- Intellectual Property Department, Fox Rothschild LLP, Princeton, NJ, United States.
Zitieren
APA
Wang, G. Y., Hao, J. M., & Chen, J. G. (2026). International perspectives on AI-driven pharmaceutical IP challenges. Frontiers in Digital Health, 8. https://doi.org/10.3389/fdgth.2026.1774406
Vancouver
Wang GY, Hao JM, Chen JG. International perspectives on AI-driven pharmaceutical IP challenges. Frontiers in Digital Health. 2026;8. doi:10.3389/fdgth.2026.1774406
BibTeX
@article{Wang2026,
author = {Wang, Grace Y and Hao, Jian-Ming and Chen, Joe G},
title = {International perspectives on AI-driven pharmaceutical IP challenges},
journal = {Frontiers in Digital Health},
year = {2026},
volume = {8},
doi = {10.3389/fdgth.2026.1774406}
}
EUVIMED